Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 104,906 |
|
|||||
| News | - | ||||||
| Day High | 2.9324 | Low High |
|||||
| Day Low | 2.53 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.25 | 9.77% | 2.81 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.56 | 2.53 | 2.9324 | 2.86 | 2.56 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 569 | 104,906 | $ 2.79 | $ 292,435 | - | 2.00 - 70.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:50:49 | 10 | $ 2.80 | USD |
MyMD Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.98M | 2.09M | - | 0 | -8.22M | -3.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MyMD Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.00 | 2.9324 | 2.00 | 2.48 | 41,188 | 0.81 | 40.50% |
| 1 Month | 2.29 | 3.50 | 2.00 | 2.61 | 647,798 | 0.52 | 22.71% |
| 3 Months | 4.89 | 5.289 | 2.00 | 3.43 | 496,719 | -2.08 | -42.54% |
| 6 Months | 12.546 | 14.727 | 2.00 | 6.73 | 985,303 | -9.74 | -77.60% |
| 1 Year | 52.80 | 70.50 | 2.00 | 18.76 | 822,745 | -49.99 | -94.68% |
| 3 Years | 123.60 | 298.50 | 2.00 | 52.98 | 423,011 | -120.79 | -97.73% |
| 5 Years | 162.90 | 298.50 | 2.00 | 57.51 | 441,556 | -160.09 | -98.28% |
MyMD Pharmaceuticals Description
| MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. |
